Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies

about

Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies

Item

http://www.wikidata.org/entity/Q58583047

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies

@en

Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies

@nl

type

Item

label

Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies

@en

Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies

@nl

prefLabel

Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies

@en

Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies

@nl

P1476

Who Wants to Switch? Gauging Patient Interest in Novel Antiretroviral Therapies

@en

P2093

Amy Hobbie

http://www.w3.org/2001/XMLSchema#string

Andrew Weinhold

http://www.w3.org/2001/XMLSchema#string

Caroline B Derrick

http://www.w3.org/2001/XMLSchema#string

Jan Ostermann

http://www.w3.org/2001/XMLSchema#string

Nathan M Thielman

http://www.w3.org/2001/XMLSchema#string

Noor Alshareef

http://www.w3.org/2001/XMLSchema#string

Sharon B Weissman

http://www.w3.org/2001/XMLSchema#string

Valerie Yelverton

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of HIV-1 infection with early antiretroviral therapy

Implementation challenges for long-acting antivirals as treatment.

Pharmacokinetics of long-acting tenofovir alafenamide (GS-7340) subdermal implant for HIV prophylaxis.

Racial differences in attitudes toward innovative medical technology

Trust in physicians and racial disparities in HIV care

Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials.

Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women.

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial.

Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy.

Single tablet HIV regimens facilitate virologic suppression and retention in care among treatment naïve patients.

P304

ofy247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/OFID/OFY247

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30364593

http://www.w3.org/2001/XMLSchema#string

P932

6197380

http://www.w3.org/2001/XMLSchema#string